Fine-tuned finish for moderate to severe dynamic perioral rhytids
Fine-tuned finish for moderate to severe dynamic perioral rhytids
The first and only FDA-approved filler for injection into both the superficial dermis and dermis to treat dynamic perioral rhytids.
May be appropriate for patients who:
- Need correction with a superficially placed filler in the dermis
- Desire a natural look and feel without unwanted heaviness
Results that last up to
12 months*
Results that last up to 12 months*
Patient was treated with 0.3 mL RHA Redensity™ in perioral rhytids; 1.9 mL RHA® 3, including 1.0 mL for direct nasolabial fold correction, 0.5 mL in marionette lines, and 0.4 mL in oral commissures; 1.6 mL RHA® 4 for indirect nasolabial fold correction. Images captured before and two weeks after treatment. Results may vary.
*Clinical effectiveness and safety were demonstrated in a 12-month clinical trial for the treatment of moderate to severe perioral rhytids.
RHA REDENSITY™ INJECTION
Indicated for injection into the dermis and superficial dermis of the face, for the correction of moderate to severe dynamic perioral rhytids in adults 22 or older
- Thin gauge needle (30 G x ½”)
- Inserted into superficial dermis or dermis using serial puncture, linear threading or fanning, raising a wheal with needle bevel at 5° to 15° angle to the skin surface
Previous
Next
OTHER PRODUCTS
